US-based medical implant surface technology company, Titan Spine, has received US Food and Drug Administration (FDA) clearance for its Endoskeleton TAS system, incorporating an ALIF device with integrated fixation screws.

The Endoskeleton TAS features similar macro, micro, and nano-surface textures to the company’s Endo TA ALIF device, which has been shown to bring a superior osteogenic response in comparison to other commercially available interbody materials.

In addition, the TAS consists of three integrated grit-blasted screws that allow up to 10° of medial / lateral or anterior / posterior angulation.

The ALIF device with integrated screws prevents the need for supplemental fixation.